Product
Delta Inulin-CpG55.2
1 clinical trial
2 indications
Indication
InfluenzaIndication
Influenza ImmunizationClinical trial
A Phase I Study to Assess the Safety, Reactogenicity and Immunogenicity of Two Quadrivalent Seasonal Influenza Vaccines (Fluzone(R) or Flublok(R)) With or Without One of Two Adjuvants (AF03 or Advax-CpG55.2) in Healthy Adults 18-45 Years of AgeStatus: Completed, Estimated PCD: 2020-09-18